CompuGroup Medical US

Two years. One regulatory fight. Here's how we got here.

Catch up on the full story, including what the bill could mean for your lab: https://www.cgm.com/usa_en/articles/articles/lab/the-enhancing-clia-act-of-2026-what-h-r-8890-means-for-laboratory-developed-tests.html

Big changes have been proposed for how laboratory developed tests (LDTs) are regulated.

The Enhancing CLIA Act of 2026 (H.R. 8890) would permanently settle a two-year fight over whether LDTs are overseen by the FDA or by CMS under CLIA, while adding requirements labs haven't seen before.

We break down what's in the bill, where it stands, and what it could mean for your lab: https://www.cgm.com/usa_en/articles/articles/lab/the-enhancing-clia-act-of-2026-what-h-r-8890-means-for-laboratory-developed-tests.html

Is your anatomic pathology lab juggling multiple vendors for your LIS, billing, and remote patient monitoring?

You're not alone, and the friction between those systems is costing more than most lab directors realize. We put together a practical guide to consolidating around a single vendor, including what questions to ask, what the 2026 Medicare RPM updates mean for practice-affiliated labs, and what a real-world consolidation looks like.

Read it here → https://www.cgm.com/usa_en/articles/articles/lab/anatomic-pathology-labs-the-case-for-one-vendor-for-lis-rcm-and-rpm.html

If your practice is running a remote patient monitoring program, 2026 quietly doubled your potential revenue—without adding a single patient.

Two new Medicare CPT® codes took effect January 1.

Work you were doing in 2025 that went unpaid? Now it will be reimbursed.

We break down what changed, what the revenue math looks like at scale, and what practices should audit right now in our latest article:

🔗 2026 Medicare RPM code changes → https://www.cgm.com/usa_en/articles/articles/2026-medicare-rpm-code-changes-what-your-practice-is-leaving-on-the-table.html